Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Bai, Chunmei, Prof, Wang, Wei, MD, Li, Jie, Prof, Yu, Xianjun, Prof, Li, Zhiping, Prof, Li, Enxiao, Prof, Yuan, Xianglin, Prof, Chi, Yihebali, Prof, Yin, Yongmei, Prof, Lou, Wenhui, Prof, Xu, Nong, Prof, Bai, Yuxian, Prof, Zhang, Tao, Prof, Xiu, Dianrong, Prof, Wang, Xiuwen, Prof, Yuan, Ying, Prof, Chen, Jia, Prof, Qin, Shukui, Prof, Jia, Ru, MD, Lu, Ming, MD, Cheng, Yuejuan, MD, Zhou, Zhiwei, Prof, Li, Jing, MD, He, James, MD, Su, Weiguo, PhD

Get full text